SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-05-082750
Filing Date
2005-04-22
Accepted
2005-04-22 16:52:56
Documents
1
Effectiveness Date
2005-04-22

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL ddfan14a.htm DFAN14A 35614
  Complete submission text file 0001193125-05-082750.txt   37576
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-26727 | Film No.: 05767951
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORBIMED ADVISORS LLC 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017
Business Address C/O ORBIMED ADVISORS LLC 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017 212-739-6400
Caduceus Capital Master Fund LTD (Filed by) CIK: 0001324238 (see all company filings)

IRS No.: 201983485 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DFAN14A